🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/07/2010 | 33,40 | 33,68 | 33,02 | 33,45 | +0,92% | 2,00% | 15.270.722 |
| 28/07/2010 | 33,53 | 33,79 | 33,03 | 33,15 | -1,25% | 2,25% | 10.175.870 |
| 27/07/2010 | 33,70 | 33,96 | 33,40 | 33,57 | -0,26% | 1,67% | 13.285.810 |
| 26/07/2010 | 33,40 | 33,68 | 33,22 | 33,65 | +1,15% | 1,40% | 10.096.956 |
| 23/07/2010 | 33,56 | 33,56 | 32,83 | 33,27 | -0,88% | 2,16% | 16.431.802 |
| 22/07/2010 | 33,74 | 33,89 | 33,40 | 33,57 | -0,03% | 1,47% | 16.482.944 |
| 21/07/2010 | 33,86 | 34,06 | 33,38 | 33,58 | -1,32% | 2,00% | 13.429.491 |
| 20/07/2010 | 33,89 | 34,03 | 33,59 | 34,03 | -0,39% | 1,29% | 14.684.262 |
| 19/07/2010 | 34,29 | 34,46 | 34,06 | 34,16 | -0,31% | 1,17% | 10.604.188 |
| 16/07/2010 | 34,86 | 35,11 | 34,24 | 34,27 | -1,59% | 2,52% | 17.374.792 |
| 15/07/2010 | 34,59 | 34,89 | 34,26 | 34,82 | +0,80% | 1,82% | 11.518.673 |
| 14/07/2010 | 34,55 | 34,70 | 34,19 | 34,54 | -0,69% | 1,49% | 11.736.657 |
| 13/07/2010 | 34,48 | 35,02 | 34,38 | 34,78 | +1,00% | 1,85% | 13.523.497 |
| 12/07/2010 | 34,54 | 34,58 | 34,20 | 34,44 | -0,58% | 1,11% | 13.223.245 |
| 09/07/2010 | 34,27 | 34,73 | 34,08 | 34,64 | +1,23% | 1,89% | 12.569.083 |
| 08/07/2010 | 34,23 | 34,23 | 33,71 | 34,22 | +1,21% | 1,51% | 16.314.426 |
| 07/07/2010 | 33,18 | 33,84 | 32,84 | 33,81 | +2,25% | 2,99% | 17.699.882 |
| 06/07/2010 | 32,71 | 33,10 | 32,49 | 33,06 | +1,26% | 1,87% | 15.630.396 |
| 02/07/2010 | 32,88 | 32,92 | 32,11 | 32,65 | -0,64% | 2,47% | 17.809.188 |
| 01/07/2010 | 33,23 | 33,29 | 32,11 | 32,86 | -1,52% | 3,56% | 26.815.386 |
| 30/06/2010 | 33,70 | 33,72 | 33,16 | 33,37 | -1,30% | 1,67% | 22.218.753 |
| 29/06/2010 | 33,92 | 34,16 | 33,40 | 33,81 | -1,42% | 2,25% | 23.962.206 |
| 28/06/2010 | 34,48 | 34,48 | 33,94 | 34,29 | +0,03% | 1,58% | 14.404.341 |
| 25/06/2010 | 33,97 | 34,49 | 33,66 | 34,28 | +0,90% | 2,44% | 35.498.904 |
| 24/06/2010 | 33,57 | 34,06 | 33,56 | 33,98 | +0,54% | 1,51% | 17.217.592 |
| 23/06/2010 | 33,59 | 34,03 | 33,33 | 33,80 | +0,83% | 2,07% | 13.624.629 |
| 22/06/2010 | 33,58 | 34,08 | 33,46 | 33,52 | +0,03% | 1,85% | 17.187.095 |
| 21/06/2010 | 34,39 | 34,49 | 33,31 | 33,51 | -1,54% | 3,44% | 16.317.989 |
| 18/06/2010 | 34,26 | 34,35 | 33,86 | 34,04 | -0,53% | 1,45% | 20.582.510 |
| 17/06/2010 | 34,48 | 34,59 | 33,68 | 34,22 | -0,42% | 2,63% | 18.747.358 |